Skip to content

Innovation in health: analysis of physiological signals for the prevention and monitoring of Cardiovascular and Metabolic Diseases

Geometric Analysis and Spectral Topology of Physiological Markers for preclinical indicators of Cardiovascular Diseases and Metabolic Syndrome in young and adult individuals

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
REBEC
Registry ID
RBR-5nfv46m
Enrollment
Unknown
Registered
2025-04-30
Start date
2025-05-02
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prehypertension

Interventions

A sample of 300 individuals (aged 25 to 55) of both genders will undergo morphological, behavioral, biochemical, and physiological assessments. The real data will be augmented using a synthetic base.
V03.175.500

Sponsors

Centro Acadêmico de Vitória - Universidade Federal de Pernambuco
Lead Sponsor
Centro Acadêmico de Vitória - Universidade Federal de Pernambuco
Collaborator

Eligibility

Age
25 Years to 55 Years

Inclusion criteria

Inclusion criteria: Adult individuals aged between 25 and 55 years old, of both genders, with preclinical or clinical diagnosis of cardiovascular disease (type 2 diabetes and hypertension), may present with comorbidities such as dyslipidemia or overweight and obesity. Control group – adult individuals aged between 25 years and 55 years old, of both genders, with no cardiovascular diagnosis

Exclusion criteria

Exclusion criteria: Individuals who are hospitalized or in the acute phase of the disease; who present any motor impairment; or who refuse to sign the Informed Consent Form

Design outcomes

Primary

MeasureTime frame
To develop clusters of morphological, behavioral, biochemical, and physiological indicators for the preclinical diagnosis of cardiovascular diseases. Biological signals will be captured using a device (ear thermometer prototype) and analyzed through geometric and spectral topology approaches, based on the intrinsic properties of complex networks.

Secondary

MeasureTime frame
Develop three types of multidimensional complex networks for each individual in our dataset and complex networks for the groups, enabling both individual and global spectral analysis. ;Identify differences in the spectra between these sets to understand how geometry and topology change among groups. This allows the unique characterization of an individual based on their spectrum and determines how distant they are from groups with comorbidities.;Construct multidimensional objects formed by triplets of strongly correlated variables within both developed complex networks, referred to as “triplets”, which can be dynamically used to assess whether we are moving closer to or farther from potential CVD indicators.

Countries

Brazil, France, Mozambique

Contacts

Public ContactCarol Virgínia Góis Leandro

Universidade Federal de Pernambuco

carol.leandro@ufpe.br+55(81) 2126-8000

Outcome results

None listed

Source: REBEC (via WHO ICTRP)